BriaCell Therapeutics

(NASDAQ) BCTXZ

Current Price$0.09

Market CapN/A

Since IPO (2025)-94%

5 YearN/A

1 Year-93%

1 Month-0%

BriaCell Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$30.65M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$0.09

Volume

987,080

Open

$0.08

Price

$0.09

Volume

987,080

Open

$0.08

Previous Close

$0.09

Daily Range

$0.07 - $0.10

52-Week Range

$0.06 - $1.07

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$0.09

Volume

987,080

Open

$0.08

Previous Close

$0.09

Daily Range

$0.07 - $0.10

52-Week Range

$0.06 - $1.07

Estimated Earnings Date

N/A

BCTXZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BriaCell Therapeutics

Industry

Biotechnology

Sector

Health Care

Headquarters

West Vancouver, BC V7T 2X1, CA

BCTXZ Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-147.92%

Return on Capital

-153.48%

Return on Assets

-113.23%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

987.08K

Avg. Volume

80.77K

Financials (TTM)

Gross Profit

-$26.59K

Operating Income

-$32.01M

EBITDA

-$31.48M

Operating Cash Flow

-$30.88M

Capital Expenditure

-$129.18K

Free Cash Flow

-$31.01M

Cash & ST Invst.

$22.80M

Total Debt

$0.00

BriaCell Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$7.16M

-16.9%

EBITDA

-$7.17M

-16.4%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

$22.80M

+83.0%

Total Debt

$0.00

N/A

Accounts Receivable

$2.59M

+11.3%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.13%

N/A

Return on Invested Capital

-1.36%

N/A

Free Cash Flow

-$7.21M

-0.6%

Operating Cash Flow

-$7.08M

+1.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NKGNNKGen Biotech, Inc. Common Stock

NKGNNKGen Biotech, Inc. Common Stock$0.06-0.00%

NCELNewcelX Ltd.

NCELNewcelX Ltd.$3.66-0.81%

XRTXXORTX Therapeutics Inc.

XRTXXORTX Therapeutics Inc.$2.17-1.37%

ELABPMGC Holdings Inc.

ELABPMGC Holdings Inc.$1.21+0.00%

WINTWindtree Therapeutics, Inc.

WINTWindtree Therapeutics, Inc.$0.01-5.45%

VRAXVirax Biolabs Group Limited

VRAXVirax Biolabs Group Limited$2.94-9.82%

AIMDAinos, Inc.

AIMDAinos, Inc.$1.94+8.38%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$18.07+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.16+0.04%

PATHUiPath

PATHUiPath$10.87+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.21-0.05%

RKTRocket Companies

RKTRocket Companies$15.75+0.02%

CMCSAComcast

CMCSAComcast$24.55+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$81.00+0.05%

Questions About BCTXZ

What is the current price of BriaCell Therapeutics?

BriaCell Therapeutics is trading at $0.09 per share.

What is the 52-week range for BriaCell Therapeutics?

Over the past 52 weeks, BriaCell Therapeutics has traded between $0.06 and $1.07.

How much debt does BriaCell Therapeutics have?

BriaCell Therapeutics total debt is unavailable.

How much cash does BriaCell Therapeutics have on hand?

BriaCell Therapeutics does not have cash on hand data available.

What is BriaCell Therapeutics’s dividend yield?

BriaCell Therapeutics does not currently have a dividend yield.

BriaCell Therapeutics

BriaCell Therapeutics Financials at a Glance

BCTXZ News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BriaCell Therapeutics

BCTXZ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BriaCell Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BCTXZ

What is the current price of BriaCell Therapeutics?

What is the 52-week range for BriaCell Therapeutics?

How much debt does BriaCell Therapeutics have?

How much cash does BriaCell Therapeutics have on hand?

What is BriaCell Therapeutics’s dividend yield?

Premium Investing Services